Last June 2022, AEW Energie has successfully placed a fixed-interest bond in the amount of CHF 125 million with a term of 7 years and a coupon of 1.5% led by Zürcher Kantonalbank. The proceeds of the issue
Tags :dx1
Alex Schütz has been appointed as new partner at Eversheds Sutherland. The appointment is effective as of 1 July 2022. Schütz has joined the firm in 2017 as associate and has since built a very strong
Eversheds Sutherland has advised the founder and long-time chairman Hans Jäggi on his succession and the sale of ADMEDICS, Advanced Medical Solutions, to the managing director, Rudolf Meier. ADMEDICS was founded in 2007 by Hans
Lenz & Staehelin advised the Geneva opera, the Grand Théatre de Genève, in connection with a dispute over the sale of the Opera des Nations, a wooden structure belonging to the opera. A
Gustoso Group expands into Switzerland with an investment in Burgermeister Schweiz operating the Burgermeister and Cucina restaurants in Switzerland. The founder Aydin Yildirim remains invested with a significant stake. Munich-based Group operates roughly 80 restaurants in
Lenz & Staehelin associate Didier Nsanzineza has been elected Premier Secrétaire du Jeune Barreau de l’Ordre des avocats de Genève (Chairman of Geneva Young Bar Association) by the Bar’s general assembly
Daniel Tobler has joined Burckhardt as a new partner at the Zurich office. Daniel Tobler advises private clients in matrimonial property and inheritance law matters and assists both private and institutional clients in private and
A private family office has acquired the whole outstanding share capital of Qcenter from SR Fund I. The fund was initiated and managed by Swissroc Investment and comprising a handful of local entrepreneurs. The private
Swiss biotech company, Engimmune Therapeutics completes its seed financing round raising CHF 15.5 million, co-led by Pureos Bioventures and Novo Holdings with incubation from BaseLaunch. Engimmune Therapeutics is a platform company using cutting-edge technologies
MLL’s patent team successfully represented Swisscom Switzerland in a patent infringement claim of a non-practicing entity directed at Swisscom’s product “Swisscom TV 2.0”, in particular the technology that allows specific parts of programs to
